Lantheus Holdings, Inc. Payments to Acquire Other Productive Assets
Lantheus Holdings, Inc. (LNTH) reported Payments to Acquire Other Productive Assets of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireOtherProductiveAssets · last filed 2026-02-26
- Lantheus Holdings, Inc. payments to acquire other productive assets for the quarter ending 2025-12-31 was $0.00.
- Lantheus Holdings, Inc. payments to acquire other productive assets for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Lantheus Holdings, Inc. payments to acquire other productive assets for the quarter ending 2024-12-31 was $0.00.
- Lantheus Holdings, Inc. payments to acquire other productive assets for the quarter ending 2024-09-30 was $47.00M.
- Lantheus Holdings, Inc. payments to acquire other productive assets for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Lantheus Holdings, Inc. payments to acquire other productive assets for fiscal 2024 was $80.91M, a 78.43% increase from fiscal 2023.
- Lantheus Holdings, Inc. payments to acquire other productive assets for fiscal 2023 was $45.34M, a 82.56% decline from fiscal 2022.
- Lantheus Holdings, Inc. payments to acquire other productive assets for fiscal 2022 was $260.00M.
| Period end | Payments to Acquire Other Productive Assets 3 month | Payments to Acquire Other Productive Assets 6 month | Payments to Acquire Other Productive Assets 9 month | Payments to Acquire Other Productive Assets 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-06 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $47.00M derived: sum of 2 quarters · filed 2026-02-26 | $80.91M derived: sum of 3 quarters · filed 2026-02-26 | $80.91M 10-K · filed 2026-02-26 |
| 2024-09-30 | $47.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $80.91M derived: sum of 2 quarters · filed 2025-11-06 | $80.91M 10-Q · filed 2025-11-06 | $80.91M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $33.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $33.91M 10-Q · filed 2025-08-06 | $33.91M derived: sum of 3 quarters · filed 2026-02-26 | $33.91M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-02 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $10.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $10.00M derived: sum of 3 quarters · filed 2026-02-26 | $45.34M 10-K · filed 2026-02-26 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $10.00M derived: sum of 2 quarters · filed 2024-11-06 | $45.34M 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $10.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $45.34M 10-Q · filed 2024-07-31 | ||
| 2023-03-31 | $35.34M 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | $260.00M 10-K · filed 2025-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |